WHO issues new guidance on COVID-19 self-testing
Today, WHO issued interim guidance on the Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing.
Overview
Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time and place of their choosing, termed COVID-19 self-testing. This interim guidance provides a new recommendation that COVID-19 self-testing, using SARS-CoV-2 Ag-RDTs, should be offered as part of SARS-CoV-2 testing services. It also includes implementation considerations that can guide decisions on whether, and how, to adopt self-testing in different contexts, including the populations being prioritized; the disease prevalence in that population; and the impact on accessibility of testing, health care services and result reporting.
WHO Director-General comments
During his opening remarks at a media briefing on COVID-19 earlier today, WHO Director-General Dr Tedros Adhanom Ghebreyesus said:
“Today, WHO has published new guidance on self-testing for COVID-19, recommending that self-tests should be offered in addition to professionally-administered testing services.
This recommendation is based on evidence that shows users can reliably and accurately self-test, and that self-testing may reduce inequalities in testing access.
How countries use self-testing will need to be adapted according to national priorities, local epidemiology, and the availability of resources, with community input.
We hope that our new guidance will also help to increase access to testing, which is too expensive for many low-income countries, where these tools could play an important role in expanding testing.
WHO and its partners in the ACT Accelerator are urgently seeking further funding to ensure that all countries that need self-tests will be able to receive them as quickly as possible.
In readiness for these guidelines, WHO has contacted manufacturers to encourage them to apply for prequalification of self-tests.
To date, WHO has granted emergency use listing to 5 rapid antigen tests for professional use, and we are gathering additional data to support the use of self-tests.”
